Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2014, Article ID 540242, 7 pages
http://dx.doi.org/10.1155/2014/540242
Research Article

Vanadyl Sulfate Treatment Stimulates Proliferation and Regeneration of Beta Cells in Pancreatic Islets

1Laboratory of Integrated Physiology, Faculty of Sciences of Bizerte, University of Carthage, 7021 Jarzouna, Tunisia
2Department of Pathological Anatomy, Farhat Hached University Hospital, 4000 Sousse, Tunisia

Received 23 May 2014; Revised 7 July 2014; Accepted 28 July 2014; Published 19 August 2014

Academic Editor: Giuseppe Paolisso

Copyright © 2014 Samira Missaoui et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. M. Shafer, B. M. Toner, J. T. Overdier et al., “Chemical speciation of vanadium in particulate matter emitted from diesel vehicles and urban atmospheric aerosols,” Environmental Science and Technology, vol. 46, no. 1, pp. 189–195, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Kiss, E. Kiss, E. Garribba, and H. Sakurai, “Speciation of insulin-mimetic VO(IV)-containing drugs in blood serum,” Journal of Inorganic Biochemistry, vol. 80, no. 1-2, pp. 65–73, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Yanardag, S. Bolkent, Ö. Karabulut-Bulan, and S. Tunali, “Effects of vanadyl sulfate on kidney in experimental diabetes,” Biological Trace Element Research, vol. 95, no. 1, pp. 73–85, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Koyuturk, S. Tunali, S. Bolkent, and R. Yanardag, “Effects of vanadyl sulfate on liver of streptozotocin-induced diabetic rats,” Biological Trace Element Research, vol. 104, no. 3, pp. 233–247, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Niu, W. Liu, C. Tian et al., “Effects of bis(α-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats,” European Journal of Pharmacology, vol. 572, no. 2-3, pp. 213–219, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Wei, M. Li, and W. Ding, “Effect of vanadate on gene expression of the insulin signaling pathway in skeletal muscle of streptozotocin-induced diabetic rats,” Journal of Biological Inorganic Chemistry, vol. 12, no. 8, pp. 1265–1273, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Li, J. J. Smee, W. Ding, and D. C. Crans, “Anti-diabetic effects of sodium 4-amino-2,6-dipicolinatodioxovanadium(V) dihydrate in streptozotocin-induced diabetic rats,” Journal of Inorganic Biochemistry, vol. 103, no. 4, pp. 585–589, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. K. H. Thompson, J. Lichter, C. LeBel, M. C. Scaife, J. H. McNeill, and C. Orvig, “Vanadium treatment of type 2 diabetes: a view to the future,” Journal of Inorganic Biochemistry, vol. 103, no. 4, pp. 554–558, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Badmaev, S. Prakash, and M. Majeed, “Vanadium: a review of its potential role in the fight against diabetes,” Journal of Alternative and Complementary Medicine, vol. 5, no. 3, pp. 273–291, 1999. View at Google Scholar · View at Scopus
  10. M. C. Cam, R. W. Brownsey, and J. H. McNeill, “Mechanisms of vanadium action: insulin-mimetic or insulin-enhancing agent?” Canadian Journal of Physiology and Pharmacology, vol. 78, no. 10, pp. 829–847, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. H. A. Sakurai, K. Tsuchiya, M. Nukatsuka, M. Sofue, and J. Kawada, “Insulin-like effect of vanadyl ion on streptozotocin-induced diabetic rats,” Journal of Endocrinology, vol. 126, no. 3, pp. 451–459, 1990. View at Google Scholar · View at Scopus
  12. M. T. Conconi, E. Decarlo, S. Vigolo et al., “Effects of some vanadyl coordination compounds on the in vitro insulin release from rat pancreatic islets,” Hormone and Metabolic Research, vol. 35, no. 7, pp. 402–406, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Shechter, I. Goldwaser, M. Mironchik, M. Fridkin, and D. Gefel, “Historic perspective and recent developments on the insulin-like actions of vanadium; toward developing vanadium-based drugs for diabetes,” Coordination Chemistry Reviews, vol. 237, no. 1-2, pp. 3–11, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Venkatesan, A. Avidan, and M. B. Davidson, “Antidiabetic action of vanadyl in rats independent of in vivo insulin-receptor kinase activity,” Diabetes, vol. 40, no. 4, pp. 492–498, 1991. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Tsiani and I. G. Fantus, “Vanadium compounds: biological actions and potential as pharmacological agents,” Trends in Endocrinology and Metabolism, vol. 8, no. 2, pp. 51–58, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Verma, M. C. Cam, and J. H. McNeill, “Nutritional factors that can favorably influence the glucose/insulin system: vanadium,” Journal of the American College of Nutrition, vol. 17, no. 1, pp. 11–18, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Rehder, “Biological and medicinal aspects of vanadium,” Inorganic Chemistry Communications, vol. 6, no. 5, pp. 604–617, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Bendayan and D. Gingras, “Effect of vanadate administration on blood glucose and insulin levels as well as on the exocrine pancreatic function in streptozotocin-diabetic rats,” Diabetologia, vol. 32, no. 8, pp. 561–567, 1989. View at Google Scholar · View at Scopus
  19. G. A. Dehghani, M. Sotoodeh, and G. R. Omrani, “Trophic effects of vanadium on beta-cells of STZ-induced insulin-dependent diabetic rats and evidence for long term relief of diabetes mellitus,” Indian Journal of Medical Research, vol. 110, pp. 70–75, 1999. View at Google Scholar · View at Scopus
  20. A. K. Srivastava, “Anti-diabetic and toxic effects of vanadium compounds,” Molecular and Cellular Biochemistry, vol. 206, no. 1-2, pp. 177–182, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. J. J. Mongold, G. H. Cros, L. Vian et al., “Toxicological aspects of vanadyl sulphate on diabetic rats: effects on vanadium levels and pancreatic B-cell morphology,” Pharmacology and Toxicology, vol. 67, no. 3, pp. 192–198, 1990. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Yao, M. L. Battell, and J. H. McNeill, “Acute and chronic response to vanadium following two methods of streptozotocin-diabetes induction,” Canadian Journal of Physiology and Pharmacology, vol. 75, no. 2, pp. 83–90, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Akgün-Dar, S. Bolkent, R. Yanardag, and S. Tunali, “Vanadyl sulfate protects against streptozotocin-induced morphological and biochemical changes in rat aorta,” Cell Biochemistry and Function, vol. 25, no. 6, pp. 603–609, 2007. View at Google Scholar
  24. S. Bolkent, S. Bolkent, R. Yanardag, and S. Tunali, “Protective effect of vanadyl sulfate on the pancreas of streptozotocin-induced diabetic rats,” Diabetes Research and Clinical Practice, vol. 70, no. 2, pp. 103–109, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. C. E. Heyliger, A. G. Tahiliani, and J. H. McNeill, “Effect of Vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats,” Science, vol. 227, no. 4693, pp. 1474–1477, 1985. View at Publisher · View at Google Scholar · View at Scopus
  26. G. A. Dehghani, S. Ahmadi, and G. R. Omrani, “Effects of vanadyl sulphate on glucose homeostasis in severe diabetes induced by streptozotocin in rats,” Indian Journal of Medical Research, vol. 106, pp. 481–485, 1997. View at Google Scholar · View at Scopus
  27. E. Shafrir, S. Spielman, I. Nachliel, M. Khamaisi, H. Bar-On, and E. Ziv, “Treatment of diabetes with vanadium salts: general overview and amelioration of nutritionally induced diabetes in the Psammomys obesus gerbil,” Diabetes/Metabolism Research and Reviews, vol. 17, no. 1, pp. 55–66, 2001. View at Google Scholar
  28. M. Huang, Y. Wu, N. Wang, Z. Wang, Yang X., and P. Zhao, “Is the hypoglycemic action of vanadium compounds related to the suppression of feeding?” Biological Trace Element Research, vol. 157, no. 3, pp. 242–248, 2014. View at Google Scholar
  29. M. Xie, D. Chen, F. Zhang, G. R. Willsky, D. C. Crans, and W. Ding, “Effects of vanadium (III, IV, V)-chlorodipicolinate on glycolysis and antioxidant status in the liver of STZ-induced diabetic rats,” Journal of Inorganic Biochemistry, vol. 136, pp. 47–56, 2014. View at Publisher · View at Google Scholar
  30. M. Soveid, G. A. Dehghani, and G. R. Omrani, “Long- term efficacy and safety of vanadium in the treatment of type 1 diabetes,” Archives of Iranian Medicine, vol. 16, no. 7, pp. 408–411, 2013. View at Google Scholar · View at Scopus
  31. J. Meyerovitch, Z. Farfel, J. Sack, and Y. Shechter, “Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. Characterization and mode of action,” Journal of Biological Chemistry, vol. 262, no. 14, pp. 6658–6662, 1987. View at Google Scholar · View at Scopus
  32. A. B. Goldfine, D. C. Simonson, F. Folli, M. E. Patti, and C. R. Kahn, “In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus,” Molecular and Cellular Biochemistry, vol. 153, pp. 217–231, 1995. View at Google Scholar
  33. M. C. Cam, B. Rodrigues, and J. H. McNeill, “Distinct glucose lowering and beta cell protective effects of vanadium and food restriction in streptozotocin-diabetes,” European Journal of Endocrinology, vol. 141, no. 5, pp. 546–554, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Vardatsikos, M. Z. Mehdi, and A. K. Srivastava, “Bis(maltolato)-oxovanadium (IV)-induced phosphorylation of PKB, GSK-3 and FOXO1 contributes toits glucoregulatory responses,” International Journal of Molecular Medicine, vol. 24, no. 3, pp. 303–309, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. D. C. Crans, J. J. Smee, E. Gaidamauskas, and L. Yang, “The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds,” Chemical Reviews, vol. 104, no. 2, pp. 849–902, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Scior, J. A. Guevara-García, F. J. Melendez, H. H. Abdallah, Q. T. Do, and P. Bernard, “Chimeric design, synthesis, and biological assays of a new nonpeptide insulin-mimetic vanadium compound to inhibit protein tyrosine phosphatase 1B,” Drug Design, Development and Therapy, vol. 4, pp. 231–242, 2010. View at Google Scholar
  37. T. Scior, H. Mack, J. A. G. García, and W. Koch, “Antidiabetic bis-maltolato-oxovanadium(IV): conversion of inactive trans- to bioactive cis-BMOV for possible binding to target PTP-1B,” Drug Design, Development and Therapy, vol. 2, pp. 221–231, 2008. View at Google Scholar · View at Scopus
  38. A. Mohammad, V. Sharma, and J. H. McNeill, “Vanadium increases GLUT4 in diabetic rat skeletal muscle,” Molecular and Cellular Biochemistry, vol. 233, no. 1-2, pp. 139–143, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Semiz and J. H. McNeill, “Oral treatment with vanadium of Zucker fatty rats activates muscle glycogen synthesis and insulin-stimulated protein phosphatase-1 activity,” Molecular and Cellular Biochemistry, vol. 236, no. 1-2, pp. 123–131, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Ijaz, T. Tejada, P. Catanuto et al., “Inhibition of C-jun N-terminal kinase improves insulin sensitivity but worsens albuminuria in experimental diabetes,” Kidney International, vol. 75, no. 4, pp. 381–388, 2009. View at Google Scholar
  41. A. B. Goldfine, M. E. Patti, L. Zuberi et al., “Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies,” Metabolism, vol. 49, no. 3, pp. 400–410, 2000. View at Google Scholar
  42. S. Ahmadi, S. M. Karimian, M. Sotoudeh, M. Bahadori, and G. A. Dehghani, “Pancreatic islet beta cell protective effect of oral vanadyl sulphate in streptozotocin -induced diabetic rats, an ultrastructure study,” Pakistan Journal of Biological Sciences, vol. 13, no. 23, pp. 1135–1140, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Waguri, K. Yamamoto, J. Miyagawa et al., “Demonstration of two different processes of β-cell regeneration in a new diabetic mouse model induced by selective perfusion of alloxan,” Diabetes, vol. 46, no. 8, pp. 1281–1290, 1997. View at Publisher · View at Google Scholar · View at Scopus